Latigo Biotherapeutics Statistics
NASDAQ: LTGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
15.52-0.74 (-4.55%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 15.89 +2.38%
Latigo Biotherapeutics by the numbers
Latigo Biotherapeutics has a market capitalization of $1.03 billion based on 66.30M shares outstanding. With trailing EPS of $-2.52, Latigo Biotherapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.9% below its 50-day average and 24.9% below its 200-day average.
Average daily trading volume is 397.83K shares, or about $6.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LTGO valuation vs. peer median
| Metric | LTGO | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.03B | $1.09B | -6% |
| Avg. volume | 397.83K | 699.31K | -43% |
Peer median across 8 companies: AMPH, BCAX, TRAX, JANX, LBRX, MNKD, OPK, AVLN.
Valuation
- Market cap
- $1.03B
- EPS (TTM)
- $-2.52
- Shares outstanding
- 66.30M
Price and trading
- Previous close
- 16.26
- Open
- 16.22
- Day range
- 15.27 – 16.35
- 52-week range
- 15.27 – 25.93
- Beta
- —
- Volume
- 241.51K
- Average volume
- 397.83K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 1.03B
- Forward Pe
- -7.43
- Eps
- -2.52
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 25.93
- Week52 Low
- 15.27
- Avg Volume
- 397.83K
- Shares Outstanding
- 66.30M
- Ma50
- 20.66
- Ma200
- 20.66
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -40.15%
- Pct From52w Low
- 1.64%